Two-tiered universal newborn screening strategy for severe combined immunodeficiency

Area of Science:

• Immunology
• Neonatal Screening
• Biochemistry

Background:

• Severe combined immunodeficiency (SCID) is a group of rare genetic disorders that significantly impair the immune system.
• Improved outcomes for infants with SCID are linked to early detection through universal newborn screening.
• Current screening tests lack sufficient accuracy for widespread SCID detection.

Purpose of the Study:

• To evaluate a two-tiered screening strategy to enhance the accuracy of newborn screening for SCID.
• To assess the combined diagnostic performance of interleukin-7 (IL-7) and T-cell receptor excision circles (TRECs) assays.

Main Methods:

• A pilot study was conducted using dried blood samples from patients.
• Two tests for lymphopenia were employed: interleukin-7 (IL-7) assay and TRECs assay.
• The accuracy metrics (sensitivity and specificity) of individual tests and the combined two-tiered strategy were analyzed.

Main Results:

• IL-7 screening demonstrated a specificity of 96.1% and TRECs screening had a specificity of 92.3%.
• The combined two-tiered strategy achieved 100% specificity (97-100% CI).
• Individual test sensitivities were 85% for IL-7 and 100% for TRECs.

Conclusions:

• A two-tiered screening strategy combining IL-7 and TRECs assays shows potential for high accuracy in SCID newborn screening.
• This strategy may be accurate enough to enable universal SCID screening.
• Further validation in a prospective trial is recommended.